Required section · Section 3 of 6
What can turn a valid draw into a misleading result
A basal, single time-point cortisol or ACTH answers a screening question only. Deciding whether the adrenal gland has functional reserve, or whether the HPA axis will appropriately suppress, requires a dynamic test: a stimulation test for suspected insufficiency, or a suppression test for suspected excess. The Endocrine Society's adrenal insufficiency guideline frames the cosyntropin (synthetic ACTH1-24) stimulation test as a reserve question: give exogenous ACTH and observe whether the adrenal cortex can respond. A stimulated cortisol that stays below the assay-specific cutoff supports insufficiency. The Endocrine Society's Cushing syndrome guideline frames the overnight low-dose dexamethasone suppression test, late-night salivary cortisol, and 24-hour urine free cortisol as feedback questions: give exogenous glucocorticoid, or sample at the expected nadir, and ask whether the axis suppresses appropriately. Random serum cortisol, random plasma ACTH, and high-dose dexamethasone testing are not recommended as initial Cushing syndrome screening.
Every dose, sampling time, and numeric cutoff in dynamic testing is assay-dependent and governed by the local controlled procedure, not by a portable universal number. Under CLIA (42 CFR 493.1253), a laboratory using an unmodified FDA-cleared test must verify that the manufacturer's reference interval fits its own patient population, and a laboratory using a modified or laboratory-developed test must establish its own reference intervals and performance specifications. A cutoff is therefore always the assay's or the local procedure's, never a portable fixed number.
In a two-site assay, extreme antigen excess can saturate both capture and signal antibodies, causing paradoxically low signal; dilution can restore proportional recovery.
Illustrative drawing — this picture was drawn rather than captured.
| Factor | Affected analyte | Effect | Resolution |
|---|---|---|---|
| Oral estrogen (raises CBG) | Total cortisol | Raises total cortisol without proportionate free cortisol rise | Note estrogen use; consider free cortisol context |
| CYP3A4 inducer (e.g., rifampin) | Dexamethasone suppression test | Speeds dexamethasone clearance, falsely non-suppressed | Simultaneous dexamethasone level, per local procedure |
| Prednisolone cross-reactivity | Immunoassay cortisol | Falsely elevated measured cortisol | Check medication list; confirm assay's cross-reactivity profile |
| Macroprolactin | Total prolactin | Falsely elevated in an asymptomatic patient | PEG precipitation screen |
| Hook effect with large mass | Prolactin | Falsely low/near-normal despite very high true value | Serial dilution |
Knowledge checks
Reading and checks are open. Sign in only to save.
Knowledge check 1
Knowledge check 2
Section status
Finish this section
Reading and checks are open. Sign in only to save.
The module finishes after every required section is marked done and every check in those sections is correct.